Acer Medical Inc.

As of June 30, 2026, Acer Medical Inc. carries a market capitalization of 1.43B, placing it among publicly traded companies globally. Its enterprise value stands at 1.28B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Acer Medical Inc. has 15.23M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Acer Medical Inc. maintains a current ratio of 5.14, meaning it holds 5.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Acer Medical Inc.'s stock has declined approximately 24.58% over the past 52 weeks. The 50-day moving average sits at 91.07, while the 200-day moving average is 98.77.

As of June 30, 2026, Acer Medical Inc. holds 153.77M in cash and equivalents against - - in total debt, resulting in a net debt position of -153.77M. Total book value stands at 155.77M, with working capital of 146.04M providing operational flexibility.

Acer Medical Inc.'s most recent stock split took place on September 22, 2022 with a 440:457 split ratio.